This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Number of unsuccessful lung cancer drugs in the United States from 1998 to 2014
This statistic depicts the number of unsuccessful lung cancer drugs that were developed in the United States from 1998 to 2014. In 2011, there were 13 unsuccessfully developed lung cancer drugs. Since 1998, there have been 167 total medicines being developed for lung cancer that were discontinued, suspended, or had no development reported and 10 approved medications.
Loading statistic...
| Number of drugs no longer under development | |
|---|---|
| 2014 | 6 |
| 2013 | 23 |
| 2012 | 11 |
| 2011 | 13 |
| 2010 | 14 |
| 2009 | 11 |
| 2008 | 15 |
| 2007 | 25 |
| 2006 | 6 |
| 2005 | 7 |
| 2004 | 11 |
| 2003 | 4 |
| 2002 | 8 |
| 2001 | 4 |
| 2000 | 3 |
| 1999 | 4 |
| 1998 | 2 |
© Statista 2018
More information
Other interesting statistics
Number of active physicians in the U.S. 2018 by specialty area
+Global oncology revenue by top ten pharmaceutical companies 2017 and 2024
+Deaths by cancer in the U.S. 1950-2016
Global top pharmaceutical companies by oncology market share 2017 and 2024
+Global death rate - leading causes 2016
+Bristol-Myers Squibb's top products based on revenue 2008-2017
Statistics on "Oncology"
Popular Related Keywords
- success
- lung cancer
- abandonment
- cancer drugs
- Show more
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Unsuccessful developing melanoma drugs in the U.S. 1998-2014
- Unsuccessful developing brain cancer drugs in the U.S. 1998-2014
- Average prices of Gleevec - selected countries 2013
- Revenue as a part of R&D spending for select cancer drugs 2017
- Revenue since approval for select cancer drugs 2017
- Italy: consumption of cancer drugs 2017, by region
- Net price index for cancer products in developed markets 2014
- U.S. average invoice price increase for oncology brands 2012-2017
- Metastatic cancer treatment market worldwide 2017 and 2025
- Italy: number of clinical trials for rare diseases 2017, by funding institution
- Italy: public expenditure on innovative drugs 2015-2017
- Italy: public expenditure on the most prescribed drugs 2017, by category
- Anti-cancer drugs estimated market size in South Korea 2014-2020
- Italy: number of clinical trials for rare diseases 2017, by type of drug
- Italy: number of clinical trials 2017, by type of drug
- Top cancer drugs paid by Medicare Part B by sales price per dosage 2014
- Worldwide revenue of cancer drugs
- Cancer drugs on the world market 2010
- Proportion of cancer drugs on the world pharmaceutical market
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2017
